0CF Stock Chart & Stats
€0.13
€0.00(0.00%)
At close: 4:00 PM EST
€0.13
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.19
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€7.34M
Enterprise Value€216.62
Total Cash (Recent Filing)€3.05M
Total Debt (Recent Filing)€77.43M
Price to Earnings (P/E)―
Beta2.14
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding183,219,120
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.01
Revenue Forecast (FY)€10.38M
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationOperating cash flow turning positive indicates core operations are beginning to generate cash rather than consume it. Over the coming months sustained OCF can improve liquidity, reduce reliance on external financing for working capital, and support continued commercialization even though free cash flow is still negative.
Proprietary Bio-based ChemistryOrganoClick's proprietary bio-based chemistry aligns with long-term structural demand for sustainable materials across wood, textiles and surface treatments. This IP-driven product set supports repeat industrial demand, differentiation versus fossil-based incumbents, and potential for licensing or higher value-added sales over months.
Sizeable Asset BaseA relatively large asset base provides capacity to support production scale-up, working-capital needs, and R&D investments. Over a 2–6 month horizon these assets can underpin contract fulfillment, serve as collateral for financing, and give management optionality while pursuing margin recovery.
Bears Say
Declining Revenue TrendA persistent decline and inconsistent top-line performance undermines the company's ability to spread fixed costs and achieve scale benefits. Without revenue stabilization, margin recovery and sustainable cash generation are harder to achieve, increasing execution risk for strategic initiatives over several months.
Weak Margins And Sustained LossesLow gross margins and deep net losses indicate limited pricing power or a high-cost structure relative to revenue. This constrains reinvestment in growth and makes profitability highly sensitive to small volume or cost swings, requiring structural product- or cost-led changes to achieve lasting improvement.
High Leverage And Thin EquityVery high leverage with a thin equity base elevates refinancing and solvency risk, limiting strategic flexibility. Over a medium-term horizon, any further cash shortfalls could stress liquidity, increase financing costs, and constrain the firm's ability to invest in commercialization or R&D needed to reverse poor margins.
OrganoClick AB News
0CF FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was <€0.01 and its highest was €0.19 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is €7.34M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Aug 12, 2026 which is in 10 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on May 06, 2026. The company reported -€0.001 earnings per share for the quarter, beating the consensus estimate of -€0.002 by <€0.001.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -€0.001 in its last earnings report, beating expectations of -€0.002. Following the earnings report the stock price went down -20%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in DE:0CF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―